• al­le­mand
• anglais
• français

Phy­sio­lo­gic FDG upt­ake in the ovary toge­ther with an ab­do­mi­nal wall lei­o­myo­ma mi­mi­cking me­ta­sta­si­zing ova­ri­an can­cer on PET/CT ima­ging
Schwarz EI, Ra­mach C, Mende KA, Stro­bel K
Clin Nucl Med. 2009 Apr;34(4):249-50

Sta­ging pa­thways in re­cur­rent co­lo­rec­tal car­ci­no­ma: is contrast-​enhanced 18F-FDG PET/CT the dia­gnostic tool of choice?
Soyka JD, Veit-​Haibach P, Stro­bel K, Brei­ten­stein S, Tschopp A, Mende KA, Lago MP, Hany TF
J Nucl Med. 2008 Mar;49(3):354-61

Time-​resolved, high re­so­lu­ti­on contrast-​enhanced MRA of dia­ly­sis sh­unts using the CEN­TRA key­ho­le tech­ni­que with par­al­lel ima­ging, Jour­nal of Ma­gne­tic Re­so­nan­ce Ima­ging
Mende KA, Fro­eh­lich JM, von Wey­marn C, Hoo­ge­veen R, Kist­ler T, Zol­li­ko­fer CL, Wentz KU
J Magn Reson Ima­ging. 2007 Apr;25(4):832-40

Im­pai­red ex­pres­si­on of the cell cycle re­gu­la­tor BTG2 is com­mon in clear cell renal cell car­ci­no­ma
Struck­mann K, Schraml P, Simon R, El­men­horst K (Ge­burts­na­me von Mende KA), Mir­la­cher M, Ko­no­nen J, Moch H
Can­cer Res. 2004 Mar 1;64(5):1632-8